Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 23-Sep-24 4:15 PM View:  | Verrica Pharmaceuticals Inc. (VRCA) | 19-Sep-24 | Gift | 2,675,610 | -- | -- | 19% 13.81M to 16.48M | |
| 23-Sep-24 4:15 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 19-Sep-24 | Gift | 2,675,610 | -- | -- | (16%) 16.48M to 13.81M | |
| 16-Sep-24 4:05 PM View: | Liquidia Corp (LQDA) | 12-Sep-24 | Purchase | 337,078 | $8.90 | $2,999,990.00 | 5% 6.27M to 6.6M | |
| 01-Jul-24 8:00 AM View: | Taysha Gene Therapies, Inc. (TSHA) | 27-Jun-24 | Private Purchase | 1,333,330 | $2.25 | $3,000,000.00 | 6% 23.52M to 24.85M | |
| 24-Jun-24 9:39 PM View: | Liquidia Corp (LQDA) | 20-Jun-24 | Grant | 20,359 | -- | -- | < 1% 6.25M to 6.27M | |
| 18-Dec-23 5:00 PM View: | Liquidia Corp (LQDA) | 14-Dec-23 | Market Purchase | 279,330 | $7.16 | $2,000,000.00 | 5% 5.97M to 6.25M | (5%) |
| 20-Nov-23 7:35 AM View: | Taysha Gene Therapies, Inc. (TSHA) | 17-Nov-23 | Private Purchase | 100,000 | $1.63 | $163,000.00 | < 1% 23.42M to 23.52M | |
| 16-Aug-23 8:57 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 16-Aug-23 | Private Purchase | 16,466,700 | $0.90 | $14,820,000.00 | 237% 6.95M to 23.42M | |
| 24-Jul-23 6:47 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 24-Jul-23 | Private Purchase | 200,000 | $5.02 | $1,004,000.00 | 1% 15.39M to 15.59M | |
| 02-Nov-22 4:09 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 31-Oct-22 | Private Purchase | 1,500,000 | $2.00 | $3,000,000.00 | 28% 5.45M to 6.95M | |
| 05-Jul-22 4:10 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 05-Jul-22 | Private Purchase | 4,761,900 | $2.10 | $10,000,000.00 | 45% 10.63M to 15.39M | |
| 19-Apr-22 4:30 PM View: | Liquidia Corp (LQDA) | 18-Apr-22 | Private Purchase | 392,156 | $5.10 | $2,000,000.00 | 8% 5.14M to 5.53M | |
| 20-Apr-22 4:36 PM View: | Liquidia Corp (LQDA) | 31-Mar-22 | Grant | 435,674 | -- | -- | 8% 5.53M to 5.97M | |
| 04-Feb-22 8:28 AM View: | Taysha Gene Therapies, Inc. (TSHA) | 03-Feb-22 | Purchase | 50,000 | $7.84 | $392,000.00 | < 1% 5.37M to 5.42M | |
| 04-Feb-22 8:28 AM View: | Taysha Gene Therapies, Inc. (TSHA) | 03-Feb-22 | Purchase | 26,602 | $7.84 | $208,560.00 | < 1% 5.42M to 5.45M | |
| 04-Feb-22 8:28 AM View: | Taysha Gene Therapies, Inc. (TSHA) | 02-Feb-22 | Private Purchase | 58,000 | $7.77 | $450,660.00 | 1% 5.25M to 5.31M | |
| 04-Feb-22 8:28 AM View: | Taysha Gene Therapies, Inc. (TSHA) | 02-Feb-22 | Purchase | 67,000 | $7.77 | $520,590.00 | 1% 5.31M to 5.37M | |
| 06-Dec-21 8:20 AM View: | Verrica Pharmaceuticals Inc. (VRCA) | 03-Dec-21 | Market Purchase | 19,977 | $9.22 | $184,188.00 | < 1% 10.61M to 10.63M | < 1% |
| 06-Dec-21 8:20 AM View: | Verrica Pharmaceuticals Inc. (VRCA) | 02-Dec-21 | Market Purchase | 30,023 | $9.45 | $283,717.00 | < 1% 10.58M to 10.61M | (2%) |
| 29-Nov-21 5:01 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 24-Nov-21 | Market Purchase | 2,202 | $13.19 | $29,044.40 | < 1% 5.25M to 5.25M | (4%) |
| 24-Nov-21 7:58 AM View: | Taysha Gene Therapies, Inc. (TSHA) | 23-Nov-21 | Market Purchase | 20,000 | $12.54 | $250,800.00 | < 1% 5.23M to 5.25M | |
| 14-Feb-22 10:00 PM View: | Liquidia Corp (LQDA) | 07-Sep-21 | Gift | 4,460,310 | -- | -- | 96% 4.66M to 9.12M | |
| 14-Feb-22 10:00 PM View: | Liquidia Corp (LQDA) | 07-Sep-21 | Gift | 4,460,310 | -- | -- | (49%) 9.12M to 4.66M | |
| 02-Aug-21 8:08 PM View: | Candel Therapeutics, Inc. (CADL) | 29-Jul-21 | Conversion | 1,232,910 | -- | -- | 2202% 56.0K to 1.29M | |
| 29-Jul-21 9:02 PM View: | Candel Therapeutics, Inc. (CADL) | 29-Jul-21 | Purchase | 20,000 | $7.30 | $145,944.00 | 56% 36.0K to 56.0K | |
| 29-Jul-21 9:02 PM View: | Candel Therapeutics, Inc. (CADL) | 27-Jul-21 | Purchase | 36,000 | $7.36 | $264,834.00 | 100% 0 to 36.0K | |
| 14-Feb-22 10:00 PM View: | Candel Therapeutics, Inc. (CADL) | 14-Jul-21 | Gift | 36,752 | -- | -- | (1%) 2.91M to 2.88M | |
| 14-Feb-22 10:00 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 06-Jul-21 | Gift | 739,830 | -- | -- | 8% 8.89M to 9.63M | |
| 14-Feb-22 10:00 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 06-Jul-21 | Gift | 739,830 | -- | -- | (8%) 9.63M to 8.89M | |
| 14-Feb-22 10:00 PM View: | Liquidia Corp (LQDA) | 06-Jul-21 | Gift | 3,921,080 | -- | -- | 84% 4.66M to 8.58M | |
| 14-Feb-22 10:00 PM View: | Liquidia Corp (LQDA) | 06-Jul-21 | Gift | 3,921,080 | -- | -- | (46%) 8.58M to 4.66M | |
| 08-Jul-21 6:35 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Conversion Duplicate | 3,608,470 | -- | -- | 4022% 89.71K to 3.7M | |
| 08-Jul-21 6:35 PM View: | Acumen Pharmaceuticals, Inc. (ABOS) | 06-Jul-21 | Purchase Duplicate | 312,500 | $16.00 | $5,000,000.00 | 8% 3.7M to 4.01M | |
| 17-May-21 7:48 AM View: | Taysha Gene Therapies, Inc. (TSHA) | 14-May-21 | Market Purchase | 12,000 | $20.98 | $251,760.00 | < 1% 5.22M to 5.23M | (< 1%) |
| 15-Apr-21 9:24 AM View: | Liquidia Corp (LQDA) | 13-Apr-21 | Market Purchase | 198,413 | $2.52 | $500,001.00 | 4% 4.94M to 5.14M | 4% |
| 29-Mar-21 9:12 AM View: | Verrica Pharmaceuticals Inc. (VRCA) | 25-Mar-21 | Market Purchase | 739,830 | $14.75 | $10,912,500.00 | 8% 9.84M to 10.58M | (10%) |
| 16-Feb-21 10:00 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 31-Dec-20 | Gift | 80,000 | -- | -- | (2%) 5.3M to 5.22M | |
| 30-Sep-20 4:37 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 28-Sep-20 | Conversion | 5,295,310 | -- | -- | 100% 0 to 5.3M | |
| 21-Aug-20 7:44 AM View: | Verrica Pharmaceuticals Inc. (VRCA) | 20-Aug-20 | Market Purchase | 20,000 | $9.09 | $181,800.00 | < 1% 9.82M to 9.84M | 32% |
| 19-Aug-20 8:40 AM View: | Verrica Pharmaceuticals Inc. (VRCA) | 18-Aug-20 | Market Purchase | 10,000 | $8.55 | $85,500.00 | < 1% 9.81M to 9.82M | 40% |
| 18-Aug-20 8:35 AM View: | Verrica Pharmaceuticals Inc. (VRCA) | 17-Aug-20 | Market Purchase | 6,000 | $6.92 | $41,520.00 | < 1% 9.8M to 9.81M | 74% |
| 17-Aug-20 9:30 AM View: | Verrica Pharmaceuticals Inc. (VRCA) | 14-Aug-20 | Market Purchase | 50,000 | $6.51 | $325,500.00 | < 1% 9.75M to 9.8M | 84% |
| 17-Aug-20 9:30 AM View: | Verrica Pharmaceuticals Inc. (VRCA) | 13-Aug-20 | Market Purchase | 108,500 | $6.41 | $695,485.00 | 1% 9.64M to 9.75M | 87% |
| 12-Nov-19 4:38 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition (change in control) | 12,979,000 | $27.50 | $356,923,008.00 | (88%) 14.76M to 1.78M | |
| 12-Nov-19 4:38 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition (change in control) | 1,783,230 | $27.50 | $49,038,700.00 | (100%) 1.78M to 0 | |
| 10-Oct-19 5:03 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 10-Oct-19 | Market Purchase | 6,900 | $15.05 | $103,845.00 | < 1% 9.64M to 9.64M | (20%) |
| 10-Oct-19 5:03 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 09-Oct-19 | Market Purchase | 8,778 | $14.06 | $123,419.00 | < 1% 9.63M to 9.64M | (15%) |
| 10-Oct-19 5:03 PM View: | Verrica Pharmaceuticals Inc. (VRCA) | 08-Oct-19 | Market Purchase | 5,208 | $14.02 | $73,016.20 | < 1% 9.62M to 9.63M | (14%) |
| 12-Aug-19 4:15 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 09-Aug-19 | Purchase | 28,062 | $15.87 | $445,344.00 | < 1% 14.73M to 14.76M | |
| 08-Mar-19 8:46 AM View: | Dova Pharmaceuticals Inc. (DOVA) | 07-Mar-19 | Market Purchase | 68,000 | $7.48 | $508,640.00 | < 1% 14.67M to 14.73M | (< 1%) |